drugset / Trial / NCT00021216

Bortezomib in Treating Children With Advanced Solid Tumors

NCT00021216 ↗

Phase 1 Completed 36 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Phase I trial to study the effectiveness of bortezomib in treating children who have advanced solid tumors that have not responded to previous treatment.

Timeline

Start
2001-11
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bortezomib Small molecule — Intravenous